Searching for source:FDA

1,984 results
Record publications over time
Ironsift results are limited for unregistered users. Register or log in to see all records.

US Drug Approval A040844 – FDA – Aug 18, 2009

Glycopyrrolate

2 approved drug products. Glycopyrrolate Ingredients: Glycopyrrolate; Dosage form: tablet; Route of administration: oral; Strength: 1mg; Approval date: August 18, 2009; Marketing status: prescription. Glycopyrrolate Ingredients: Glycopyrro...
Full record
Register to view full records and disable ads.

US Drug Approval A064144 – FDA – Aug 11, 2009

Mitomycin

3 approved drug products. Mitomycin Ingredients: Mitomycin; Dosage form: injectable; Route of administration: injection; Strength: 5mg/vial; Approval date: April 30, 1998; Marketing status: prescription. Mitomycin Ingredients: Mitomycin;...
Full record

US Drug Approval A040792 – FDA – Aug 6, 2009

Carisoprodol

2 approved drug products. Carisoprodol Ingredients: Carisoprodol; Dosage form: tablet; Route of administration: oral; Strength: 250mg; Approval date: November 8, 2016; Marketing status: prescription. Carisoprodol Ingredients: Carisoprodol;...
Full record

US Drug Approval A065149 – FDA – Jul 23, 2009

Penicillin G Potassium

3 approved drug products. Penicillin G Potassium Ingredients: Penicillin G Potassium; Dosage form: injectable; Route of administration: injection; Strength: 1,000,000 units/vial; Approval date: July 23, 2009; Marketing status: prescription....
Full record

US Drug Approval A040908 – FDA – Jul 17, 2009

Propoxyphene Hydrochloride

1 approved drug product. Propoxyphene Hydrochloride Ingredients: Propoxyphene Hydrochloride; Dosage form: capsule; Route of administration: oral; Strength: 65mg; Approval date: July 17, 2009; Marketing status: discontinued.
Full record

US Drug Approval A040893 – FDA – Jun 24, 2009

Meperidine Hydrochloride

4 approved drug products. Meperidine Hydrochloride Ingredients: Meperidine Hydrochloride; Dosage form: tablet; Route of administration: oral; Strength: 50mg; Approval date: June 24, 2009; Marketing status: prescription. Meperidine Hydrochlor...
Full record

US Drug Approval A062933 – FDA – May 27, 2009

Vancomycin Hydrochloride

2 approved drug products. Vancomycin Hydrochloride Ingredients: Vancomycin Hydrochloride; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: October 29, 1992; Marketing status: prescription....
Full record

US Drug Approval A040833 – FDA – May 20, 2009

Ergocalciferol

1 approved drug product. Ergocalciferol Ingredients: Ergocalciferol; Dosage form: capsule; Route of administration: oral; Strength: 50,000 iu; Approval date: May 20, 2009; Marketing status: prescription.
Full record

US Drug Approval A040829 – FDA – May 13, 2009

Chlorpheniramine Maleate

1 approved drug product. Chlorpheniramine Maleate Ingredients: Chlorpheniramine Maleate; Dosage form: tablet, extended release; Route of administration: oral; Strength: 12mg; Approval date: May 13, 2009; Marketing status: over-the-counter.
Full record

US Drug Approval A040897 – FDA – Apr 22, 2009

Bethanechol Chloride

4 approved drug products. Bethanechol Chloride Ingredients: Bethanechol Chloride; Dosage form: tablet; Route of administration: oral; Strength: 5mg; Approval date: April 22, 2009; Marketing status: discontinued. Bethanechol Chloride Ingred...
Full record

US Drug Approval A040730 – FDA – Apr 21, 2009

Hydralazine Hydrochloride

1 approved drug product. Hydralazine Hydrochloride Ingredients: Hydralazine Hydrochloride; Dosage form: injectable; Route of administration: injection; Strength: 20mg/ml; Approval date: April 21, 2009; Marketing status: prescription.
Full record
Register to view full records and advanced analytics.

US Drug Approval A040905 – FDA – Mar 30, 2009

Kalexate

2 approved drug products. Kalexate Ingredients: Sodium Polystyrene Sulfonate; Dosage form: powder; Route of administration: oral, rectal; Strength: 15gm/bot; Approval date: April 3, 2015; Marketing status: prescription. Kalexate Ingredient...
Full record

US Drug Approval A065280 – FDA – Mar 18, 2009

Cefazolin Sodium

2 approved drug products. Cefazolin Sodium Ingredients: Cefazolin Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: March 18, 2009; Marketing status: discontinued. Cefazolin Sodiu...
Full record

US Drug Approval A065296 – FDA – Mar 18, 2009

Cefazolin Sodium

1 approved drug product. Cefazolin Sodium Ingredients: Cefazolin Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 20gm base/vial; Approval date: March 18, 2009; Marketing status: discontinued.
Full record

US Drug Approval A065295 – FDA – Mar 18, 2009

Cefazolin Sodium

1 approved drug product. Cefazolin Sodium Ingredients: Cefazolin Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 10gm base/vial; Approval date: March 18, 2009; Marketing status: discontinued.
Full record

US Drug Approval A040891 – FDA – Mar 13, 2009

Promethazine Hydrochloride

1 approved drug product. Promethazine Hydrochloride Ingredients: Promethazine Hydrochloride; Dosage form: syrup; Route of administration: oral; Strength: 6.25mg/5ml; Approval date: March 13, 2009; Marketing status: prescription.
Full record

US Drug Approval A040794 – FDA – Mar 5, 2009

Methylprednisolone Acetate

2 approved drug products. Methylprednisolone Acetate Ingredients: Methylprednisolone Acetate; Dosage form: injectable; Route of administration: injection; Strength: 40mg/ml; Approval date: March 5, 2009; Marketing status: prescription. Methy...
Full record

US Drug Approval A040836 – FDA – Mar 5, 2009

Glycopyrrolate

2 approved drug products. Glycopyrrolate Ingredients: Glycopyrrolate; Dosage form: tablet; Route of administration: oral; Strength: 1mg; Approval date: March 5, 2009; Marketing status: discontinued. Glycopyrrolate Ingredients: Glycopyrrola...
Full record

US Drug Approval A065333 – FDA – Feb 24, 2009

Amoxicillin and Clavulanate Potassium

2 approved drug products. Amoxicillin and Clavulanate Potassium Ingredients: Amoxicillin; Clavulanate Potassium; Dosage form: tablet; Route of administration: oral; Strength: 250mg;eq 125mg base; Approval date: February 24, 2009; Marketing sta...
Full record

US Drug Approval A040719 – FDA – Jan 29, 2009

Methylprednisolone Acetate

2 approved drug products. Methylprednisolone Acetate Ingredients: Methylprednisolone Acetate; Dosage form: injectable; Route of administration: injection; Strength: 40mg/ml; Approval date: January 29, 2009; Marketing status: prescription. Me...
Full record

US Drug Approval A065344 – FDA – Jan 15, 2009

Amoxicillin

1 approved drug product. Amoxicillin Ingredients: Amoxicillin; Dosage form: tablet; Route of administration: oral; Strength: 875mg; Approval date: January 15, 2009; Marketing status: discontinued.
Full record
Register to view full records and receive email notifications.

US Drug Approval A040796 – FDA – Jan 12, 2009

Folic Acid

1 approved drug product. Folic Acid Ingredients: Folic Acid; Dosage form: tablet; Route of administration: oral; Strength: 1mg; Approval date: January 12, 2009; Marketing status: prescription.
Full record

US Drug Approval A062912 – FDA – Jan 7, 2009

Vancomycin Hydrochloride

2 approved drug products. Vancomycin Hydrochloride Ingredients: Vancomycin Hydrochloride; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: August 4, 1988; Marketing status: prescription....
Full record

US Drug Approval A040863 – FDA – Dec 30, 2008

Promethazine Hydrochloride

3 approved drug products. Promethazine Hydrochloride Ingredients: Promethazine Hydrochloride; Dosage form: tablet; Route of administration: oral; Strength: 12.5mg; Approval date: December 30, 2008; Marketing status: prescription. Promethazin...
Full record

US Drug Approval A040821 – FDA – Dec 29, 2008

Glycopyrrolate

2 approved drug products. Glycopyrrolate Ingredients: Glycopyrrolate; Dosage form: tablet; Route of administration: oral; Strength: 1mg; Approval date: December 29, 2008; Marketing status: prescription. Glycopyrrolate Ingredients: Glycopyr...
Full record

US Drug Approval A040883 – FDA – Dec 23, 2008

Butalbital, Acetaminophen and Caffeine

1 approved drug product. Butalbital, Acetaminophen and Caffeine Ingredients: Acetaminophen; Butalbital; Caffeine; Dosage form: tablet; Route of administration: oral; Strength: 500mg;50mg;40mg; Approval date: December 23, 2008; Marketing status...
Full record

US Drug Approval A040784 – FDA – Dec 10, 2008

Acetazolamide Sodium

1 approved drug product. Acetazolamide Sodium Ingredients: Acetazolamide Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 500mg base/vial; Approval date: December 10, 2008; Marketing status: prescription.
Full record

US Drug Approval A040904 – FDA – Dec 10, 2008

Acetazolamide

1 approved drug product. Acetazolamide Ingredients: Acetazolamide; Dosage form: capsule, extended release; Route of administration: oral; Strength: 500mg; Approval date: December 10, 2008; Marketing status: prescription.
Full record

US Drug Approval A040909 – FDA – Dec 3, 2008

Sodium Polystyrene Sulfonate

1 approved drug product. Sodium Polystyrene Sulfonate Ingredients: Sodium Polystyrene Sulfonate; Dosage form: powder; Route of administration: oral, rectal; Strength: 454gm/bot; Approval date: December 3, 2008; Marketing status: discontinued....
Full record

US Drug Approval A040864 – FDA – Dec 1, 2008

Butalbital, Acetaminophen and Caffeine

1 approved drug product. Butalbital, Acetaminophen and Caffeine Ingredients: Acetaminophen; Butalbital; Caffeine; Dosage form: tablet; Route of administration: oral; Strength: 325mg;50mg;40mg; Approval date: December 1, 2008; Marketing status:...
Full record

US Drug Approval A040827 – FDA – Nov 25, 2008

A-Methapred

1 approved drug product. A-Methapred Ingredients: Methylprednisolone Sodium Succinate; Dosage form: injectable; Route of administration: injection; Strength: eq 125mg base/vial; Approval date: November 25, 2008; Marketing status: discontinued....
Full record
Register to view full records and use our APIs.

US Drug Approval A040793 – FDA – Nov 25, 2008

A-Methapred

1 approved drug product. A-Methapred Ingredients: Methylprednisolone Sodium Succinate; Dosage form: injectable; Route of administration: injection; Strength: eq 40mg base/vial; Approval date: November 25, 2008; Marketing status: discontinued....
Full record

US Drug Approval A040845 – FDA – Nov 18, 2008

Benzphetamine Hydrochloride

1 approved drug product. Benzphetamine Hydrochloride Ingredients: Benzphetamine Hydrochloride; Dosage form: tablet; Route of administration: oral; Strength: 50mg; Approval date: November 18, 2008; Marketing status: discontinued.
Full record

US Drug Approval A040765 – FDA – Nov 12, 2008

Extended Phenytoin Sodium

1 approved drug product. Extended Phenytoin Sodium Ingredients: Phenytoin Sodium; Dosage form: capsule; Route of administration: oral; Strength: 100mg extended; Approval date: November 12, 2008; Marketing status: prescription.
Full record

US Drug Approval A040828 – FDA – Nov 5, 2008

Diethylpropion Hydrochloride

1 approved drug product. Diethylpropion Hydrochloride Ingredients: Diethylpropion Hydrochloride; Dosage form: tablet; Route of administration: oral; Strength: 25mg; Approval date: November 5, 2008; Marketing status: discontinued.
Full record

US Drug Approval A040823 – FDA – Oct 22, 2008

Carisoprodol

1 approved drug product. Carisoprodol Ingredients: Carisoprodol; Dosage form: tablet; Route of administration: oral; Strength: 350mg; Approval date: October 22, 2008; Marketing status: prescription.
Full record

US Drug Approval A065303 – FDA – Oct 22, 2008

Cefazolin Sodium

2 approved drug products. Cefazolin Sodium Ingredients: Cefazolin Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: October 22, 2008; Marketing status: prescription. Cefazolin Sod...
Full record

US Drug Approval A065317 – FDA – Oct 20, 2008

Amoxicillin and Clavulanate Potassium

1 approved drug product. Amoxicillin and Clavulanate Potassium Ingredients: Amoxicillin; Clavulanate Potassium; Dosage form: tablet; Route of administration: oral; Strength: 875mg;eq 125mg base; Approval date: October 20, 2008; Marketing statu...
Full record

US Drug Approval A065196 – FDA – Oct 15, 2008

Ceftazidime

1 approved drug product. Ceftazidime Ingredients: Ceftazidime; Dosage form: injectable; Route of administration: injection; Strength: 1gm/vial; Approval date: October 15, 2008; Marketing status: prescription.
Full record

US Drug Approval A040862 – FDA – Oct 3, 2008

Primidone

2 approved drug products. Primidone Ingredients: Primidone; Dosage form: tablet; Route of administration: oral; Strength: 50mg; Approval date: October 3, 2008; Marketing status: discontinued. Primidone Ingredients: Primidone; Dosage form:...
Full record

US Drug Approval A040785 – FDA – Sep 26, 2008

Promethazine Hydrochloride

2 approved drug products. Promethazine Hydrochloride Ingredients: Promethazine Hydrochloride; Dosage form: injectable; Route of administration: injection; Strength: 25mg/ml; Approval date: September 26, 2008; Marketing status: discontinued....
Full record
Register to view full records and receive email notifications.

US Drug Approval A040808 – FDA – Sep 24, 2008

Hydroxyzine Hydrochloride

3 approved drug products. Hydroxyzine Hydrochloride Ingredients: Hydroxyzine Hydrochloride; Dosage form: tablet; Route of administration: oral; Strength: 10mg; Approval date: September 24, 2008; Marketing status: prescription. Hydroxyzine Hy...
Full record

US Drug Approval A040901 – FDA – Sep 12, 2008

Hydralazine Hydrochloride

4 approved drug products. Hydralazine Hydrochloride Ingredients: Hydralazine Hydrochloride; Dosage form: tablet; Route of administration: oral; Strength: 10mg; Approval date: September 12, 2008; Marketing status: prescription. Hydralazine Hy...
Full record

US Drug Approval A040802 – FDA – Aug 29, 2008

Dexamethasone Sodium Phosphate

1 approved drug product. Dexamethasone Sodium Phosphate Ingredients: Dexamethasone Sodium Phosphate; Dosage form: injectable; Route of administration: injection; Strength: eq 10mg phosphate/ml; Approval date: August 29, 2008; Marketing status:...
Full record

US Drug Approval A040803 – FDA – Aug 29, 2008

Dexamethasone Sodium Phosphate

1 approved drug product. Dexamethasone Sodium Phosphate Ingredients: Dexamethasone Sodium Phosphate; Dosage form: injectable; Route of administration: injection; Strength: eq 4mg phosphate/ml; Approval date: August 29, 2008; Marketing status:...
Full record

US Drug Approval A040700 – FDA – Aug 15, 2008

Dexamethasone

1 approved drug product. Dexamethasone Ingredients: Dexamethasone; Dosage form: tablet; Route of administration: oral; Strength: 1.5mg; Approval date: August 15, 2008; Marketing status: prescription.
Full record

US Drug Approval A040907 – FDA – Aug 15, 2008

Hydrochlorothiazide

2 approved drug products. Hydrochlorothiazide Ingredients: Hydrochlorothiazide; Dosage form: tablet; Route of administration: oral; Strength: 25mg; Approval date: August 15, 2008; Marketing status: prescription. Hydrochlorothiazide Ingredi...
Full record

US Drug Approval A040772 – FDA – Aug 11, 2008

Fluorouracil

1 approved drug product. Fluorouracil Ingredients: Fluorouracil; Dosage form: injectable; Route of administration: injection; Strength: 500mg/10ml (50mg/ml); Approval date: August 11, 2008; Marketing status: discontinued.
Full record

US Drug Approval A065285 – FDA – Jul 30, 2008

Doxycycline

4 approved drug products. Doxycycline Ingredients: Doxycycline; Dosage form: tablet; Route of administration: oral; Strength: eq 50mg base; Approval date: December 8, 2005; Marketing status: prescription. Doxycycline Ingredients: Doxycycli...
Full record

US Drug Approval A065329 – FDA – Jul 24, 2008

Ceftriaxone

3 approved drug products. Ceftriaxone Ingredients: Ceftriaxone Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: July 24, 2008; Marketing status: prescription. Ceftriaxone Ingre...
Full record